Best of Hematology and Breast Cancer 2025, Phoenix

  10 Jan 2025 - 11 Jan 2025

   Scottsdale, AZ US

conference-img

Best of Hematology and Breast Cancer 2025, Phoenix

10 Jan 2025

 - 

11 Jan 2025

Scottsdale, AZ US



Focusing on a multidisciplinary approach, the event aims to integrate new advancements into patient-centered care. Designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other professionals, attendees will engage with colleagues and experts to critically evaluate data and improve patient outcomes.

Summarize the latest updates from ASH24 and SABCS24, focusing on their implications for clinical practice in managing hematologic disorders and breast cancer, Examine the study design, primary endpoints, and impact of recent and ongoing clinical trials from ASH24 and SABCS24 that have influenced current standards of care.

International Conference on Advanced Research in Health Science and Medicin

On: 25 Aug 2026

-

25 Aug 2026


International World Research Congress on Dentistry and Oral Health

On: 25 Aug 2026

-

25 Aug 2026


World Conference and Expo on Anesthesiology and Critical Care

On: 25 Aug 2026

-

25 Aug 2026


Applied Research International Conference on Pediatrics & Neonatology

On: 25 Aug 2026

-

25 Aug 2026


Asian Symposium on Advancement in Hematology and Oncology

On: 25 Aug 2026

-

25 Aug 2026


International Conference on Advanced Research in Health Science and Medicin

On: 25 Aug 2026

-

25 Aug 2026


International World Research Congress on Dentistry and Oral Health

On: 25 Aug 2026

-

25 Aug 2026


World Conference and Expo on Anesthesiology and Critical Care

On: 25 Aug 2026

-

25 Aug 2026


Applied Research International Conference on Pediatrics & Neonatology

On: 25 Aug 2026

-

25 Aug 2026


Asian Symposium on Advancement in Hematology and Oncology

On: 25 Aug 2026

-

25 Aug 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

2.

New policy review highlights the importance of health-related quality of life in advanced cancer

3.

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

4.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

5.

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot